CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma

A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels in nearly 80% of patients with advanced non-Hodgkin lymphoma (NHL) in a phase 2 clinical trial, Dana-Farber Cancer Institute investigators report at the virtual 62nd American Society of Hematology (ASH) Annual Meeting. While NHL tends to be a slow-growing disease,…

Integrated anemia-SCD test demonstrates accurate results in study at 2020 ASH meeting

Researchers from Case Western Reserve University presented research today in which Hemex Health’s Gazelle platform diagnostic technology successfully tested 46 patients with 100% sensitivity and over 92.3% specificity for anemia and with 100% accuracy for hemoglobin variants. The preliminary study included blood samples collected from Cleveland-area patients studied for anemia and sickle cell disease. The…

Outdoor Yoga and Fighting Poverty

With the New York charity circuit on hiatus, here is how some philanthropists and society figures are spending their time and resources during the coronavirus crisis. Michael Kors Age: 61 Occupation: fashion designer Favorite Charities: God’s Love We Deliver, New York Restoration Project Where have you been hunkering down? During the first three months of…

Considering a Post-Pandemic Future

Welcome. Yesterday I noticed a colleague tweeting about the things he’s been missing during the pandemic that surprise him: his daily commute on the subway, making small talk with strangers. Of course we’re all missing things these days: people, traditions, normalcy. Of course we miss hugs, live theater, sporting events, dinner parties, going to the…